About Us
Who is Behind Pharm·ology
Founded in 2025 by Christoffer Wenzel Tornøe, PhD, Pharm·ology brings together over 20 years of drug development leadership experience.
Dr. Tornøe is a highly respected leader in Clinical Drug Development, Regulatory Affairs, and Portfolio Management, with a rare ability to integrate cutting-edge data science, scientific depth, strategic and operational execution, and regulatory strategy.
Most recently, he served as Corporate Project Vice President for Obesity & MASH portfolio at Novo Nordisk, where he spearheaded efforts to accelerate clinical development timelines, led strategic execution for the global obesity franchise, and chaired acquisition and integration of Inversago Pharma.
Prior to joining Novo Nordisk, Dr. Tornøe served as Pharmacometrics Team Leader at the U.S. Food & Drug Administration, equipping him with a regulatory perspective that complements his deep industry experience.
Our commitment
We believe the best drug development decisions come from combining rigorous science, robust evidence and a genuine desire to bring innovative medicines fast to patients who will ultimately benefit from your innovation.
"We are passionate about transforming drug development through quantified decision-making"
Why Choose Us
The Pharm·ology Advantage
AI-Powered Intelligence
Our proprietary QD platform leverages artificial intelligence to synthesize evidence from thousands of sources, identifying patterns and opportunities that human analysis alone might miss.
Make decisions backed by comprehensive data, not incomplete information.
Industry-Leading Expertise
Our team brings industry-leading regulatory and clinical drug development experience.
We've been in your position and understand the decisions you need to make.
Proven ROI
Clients using our strategic consulting and QD platform have reduced development timelines, differentiated their offering and optimized regulatory strategies.
Every day saved is value created for patients and stakeholders.
24/7 Platform Access
Access the QD platform anytime, anywhere. Your development decisions don't wait for business hours—neither should your decision support platform.
Regulatory Grade
Our methodologies and data comes from FDA, EMA, and other global regulatory agencies ensuring your evidence synthesis meets the highest scientific and regulatory standards.
Flexible Engagement
From strategic consulting to self-service platform access, we offer engagement models that fit your needs, budget, and timeline.
Pharm·ology ApS
contact@pharmology.dk
CVR: 45557898